Home
Scholarly Works
Final analysis of a randomized phase I study of...
Conference

Final analysis of a randomized phase I study of the C-RAF kinase inhibitor BAY 43-9006 in patients with acute myeloid leukemia

Authors

Crump M; Leber B; Buckstein R; Kassis J; Headley D; Minden M; Petrenciuc O; Maclntosh L; Seymour L; Eisenhauer E

Volume

15

Pagination

pp. 154-154

Publisher

OXFORD UNIV PRESS

Publication Date

January 1, 2004

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team